All.Proactive Investors videos with CytoDyn's CEO Nader

New Post Public Reply Private Reply Replies (2) Message Board
trding
1,892
All.Proactive Investors videos with CytoDyn's CEO Nader Pourhassan and CMO Richard Pestell (developing drug leronlimab).
$CYDY #CYDY #PRO140 CYDY #leronlimab CytoDyn #HIV CCR5 #CCR5 #TNBC #ProstateCancer #IncellDx #GvHD #NASH #PrEP #Cancer #AIDS #coloncancer #metastaticcancer #breastcancer #triplenegativebreastcancer #RheumatoidArthritis‎ #MultipleSclerosis

CytoDyn to meet with FDA on prostate-cancer test, applies HIV screening test to monotherapy trial
June 21, 2019-- NP at ASM conference hotel

https://youtu.be/xgRbNC13wZc

CytoDyn CEO talks about latest HIV trial featuring its flagship drug, leronlimab
June 17, 2019--NP Office

https://youtu.be/R_iNJnHckC4

CytoDyn CEO responds to share price rise as investors get excited about leronlimab
June 12, 2019--NP in hotel (D.C.?)

https://youtu.be/KeW2ruS_eoQ

CytoDyn to meet with FDA to finalize next steps on leronlimab drug trial for HIV
June 7, 2019--NP at hotel

https://youtu.be/-5i1WQWcL2w

CytoDyn shows value of company lies in their research and technology
June 4, 2019--NP and RP LD Micro in LA

https://youtu.be/iO0A9ePT0Ns

CytoDyn updates investors on licensing agreement potentials at shareholders meeting
May 28, 2019--NP in hotel

https://youtu.be/LDkhLOMBvs0

CytoDyn takes major step forward filing trial protocol for HIV Monotherapy
May 16, 2019--NP in hotel

https://youtu.be/H3SaJmTbJxw


CytoDyn adds new talent to its management team
May 14, 2019-- RP & NP in hotel

https://youtu.be/EeoaQtzOm10

CytoDyn to begin proof-of-concept studies for leronlimab to treat liver damage caused by NASH
May 13, 2019--NP in hotel

https://youtu.be/hVwA4RlON18

CytoDyn reports positive preclinical data, gets FDA's fast-track designation
May 8, 2019 RP & NP in studio

https://youtu.be/6JWnMmxHbY0

CytoDyn sees progress with leronlimab to treat HIV-infected patients
May 7, 2019--NP in hotel

https://youtu.be/6JWnMmxHbY0

Cytodyn has raised over 190 million dollars as they look to commercialize lead drug
May 2, 2019--NP ThinkEquity NY

https://youtu.be/4GSlo8E-SGs

CytoDyn CEO updates timeline for HIV drug, addresses share dilution concerns
April 15, 2019--NP in office

https://youtu.be/R9Js5eqOcxQ


CytoDyn teams with Samsung BioLogics, presents key data at cancer research meeting
April 4, 2019--NP in hotel and RP

https://youtu.be/VrSOs_9YVv4

CytoDyn more than doubles recovery rate in its monotherapy HIV trial
March 27, 2019 -- NP in Studio

https://youtu.be/0a4y91iTv5s

CytoDyn's HIV drug leromlimab takes a big step forward
March 18, 2019--NP syke hotel

https://youtu.be/iPrdhL7hIdc


CytoDyn files for fast-track designation for leronlimab in breast cancer treatment
March 11, 2019-- NP in office

https://youtu.be/SDMJZRqh9Ws

CytoDyn presents 'stunning' data on treatment of HIV at Seattle conference
March 08, 2019-- NP in office, RP

https://youtu.be/BwN0J3Hb4sU

FDA accepted CytoDyn’s request and plan to submit BLA on rolling basis
March 4, 2019-- NP in hotel

https://youtu.be/Ya-q20FI22Y


CytoDyn files for Orphan Drug designation to treat triple-negative breast cancer
February 21, 2019-- NP in office, RP

https://youtu.be/qh5dH7_vvWc

CytoDyn to begin preclinical studies with leronlimab for 8 different cancers
February 19, 2019-- NP & RP skype

https://youtu.be/2dc1UDDSZuY

CytoDyn CEO says FDA has offered 'a good path forward' for its HIV drug
February 5, 2019-- NP in studio

https://youtu.be/Hq27_b2loEs


CytoDyn aims to be 'paradigm-shifting' in cancer management with its platform drug leronlimab [/b
January 11, 2019-- NP & RP Bioconf San Fran.

https://youtu.be/gQWe6FXL3wk

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

VISTAR Oakland Workers Join Teamsters for Unity

Updated Category News Views 9

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Continue Reading
Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 14

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 11

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Updated Category News Views 7

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Continue Reading
Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Updated Category News Views 6

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 15

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
D2L Ventures into Vietnam with Van Lang Alliance

Updated Category News Views 10

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Continue Reading
Community Heritage Financial Declares Q3 2026 Dividend

Updated Category News Views 5

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 11

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 7

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading

Top 5 Most Recently Viewed Articles

Reklaim Welcomes Mark Thompson to Enhance Privacy Solutions

Updated Category News Views 155

Reklaim Expands Leadership Team with Mark Thompson Reklaim Ltd. (TSXV: MYID) has made an exciting move by hiring Mark Thompson, a former President at Norton, as its new Vice President of Product. This strategic addition aims to spearhead the growth and innovation of Reklaim Protect, a platform designed to fortify consumer privacy. Understanding Reklaim Protect Reklaim...

Continue Reading
HIMS Faces Class Action: Investors Eye Leadership

Updated Category News Views 8

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Continue Reading
Discover the New Summer Cannabis Offerings from Tilray Brands

Updated Category News Views 255

Introducing Tilray Brands' Vibrant Summer Cannabis Collection As summer approaches, excitement fills the air as Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading name in the cannabis and consumer goods sector, unveils its newest cannabis products designed to elevate your summer experiences. With a commitment to quality and innovation, Tilray's collection showcases...

Continue Reading
Bristol Myers Squibb Highlights 10-Year Survival Data in Melanoma

Updated Category News Views 104

Significant 10-Year Follow-Up Results for Melanoma Treatments Bristol Myers Squibb has unveiled promising data from the CheckMate-067 study, a crucial Phase 3 clinical trial. These findings, resulting from a decade's worth of follow-up, highlight the lasting survival benefits of combining Opdivo (nivolumab) with Yervoy (ipilimumab) as a first-line treatment for advanced...

Continue Reading
Discover the Innovative ecozy Ice Maker: Your Ice Solution

Updated Category News Views 153

Introducing the ecozy Ice Maker: Your New Home Ice Production Solution The ecozy ice maker has arrived to change how we create ice at home. This compact countertop appliance combines convenience with innovative features, making it a must-have for any household that appreciates efficiency and style. Enjoy Flexibility with a Dual Water Supply System What distinguishes this...

Continue Reading